Viral and Symptom Rebound in Untreated COVID-19 Infection
Rinki Deo, Manish C. Choudhary, Carlee Moser, Justin Ritz, Eric S. Daar, David A. Wohl, Alexander L. Greninger, Joseph J. Eron, Judith S. Currier, Michael D. Hughes, Davey M. Smith, Kara W. Chew, Jonathan Z. Li, the ACTIV-2/A5401 Study Team
doi: https://doi.org/10.1101/2022.08.01.22278278
Rinki Deo
1Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Manish C. Choudhary
1Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Carlee Moser
2Harvard T.H. Chan School of Public Health, Boston, MA
Justin Ritz
2Harvard T.H. Chan School of Public Health, Boston, MA
Eric S. Daar
3Lundquist Institute at Harbor-University of California, Los Angeles Medical Center, Torrance, CA
David A. Wohl
4University of North Carolina, Chapel Hill, NC
Alexander L. Greninger
5University of Washington Medical Center, Seattle, WA
Joseph J. Eron
4University of North Carolina, Chapel Hill, NC
Judith S. Currier
6David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA
Michael D. Hughes
2Harvard T.H. Chan School of Public Health, Boston, MA
Davey M. Smith
7University of California, San Diego, San Diego, CA
Kara W. Chew
6David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA
Jonathan Z. Li
1Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Data are available under restricted access due to ethical restrictions. Access can be requested by submitting a data request at https://submit.mis.s-3.net/ and will require the written agreement of the AIDS Clinical Trials Group (ACTG) and the manufacturer of the investigational product. Requests will be addressed as per ACTG standard operating procedures. Completion of an ACTG Data Use Agreement may be required. All analyses were performed using code available in standard software packages. No new code was developed for this manuscript.
Posted August 02, 2022.
Viral and Symptom Rebound in Untreated COVID-19 Infection
Rinki Deo, Manish C. Choudhary, Carlee Moser, Justin Ritz, Eric S. Daar, David A. Wohl, Alexander L. Greninger, Joseph J. Eron, Judith S. Currier, Michael D. Hughes, Davey M. Smith, Kara W. Chew, Jonathan Z. Li, the ACTIV-2/A5401 Study Team
medRxiv 2022.08.01.22278278; doi: https://doi.org/10.1101/2022.08.01.22278278
Viral and Symptom Rebound in Untreated COVID-19 Infection
Rinki Deo, Manish C. Choudhary, Carlee Moser, Justin Ritz, Eric S. Daar, David A. Wohl, Alexander L. Greninger, Joseph J. Eron, Judith S. Currier, Michael D. Hughes, Davey M. Smith, Kara W. Chew, Jonathan Z. Li, the ACTIV-2/A5401 Study Team
medRxiv 2022.08.01.22278278; doi: https://doi.org/10.1101/2022.08.01.22278278
Subject Area
Subject Areas
- Addiction Medicine (347)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2637)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12211)
- Forensic Medicine (10)
- Gastroenterology (758)
- Genetic and Genomic Medicine (4087)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2646)
- Health Policy (1003)
- Hematology (362)
- HIV/AIDS (850)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3862)
- Nursing (209)
- Nutrition (577)
- Oncology (2022)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6516)
- Radiology and Imaging (1398)
- Respiratory Medicine (871)
- Rheumatology (404)
- Sports Medicine (342)
- Surgery (444)
- Toxicology (52)
- Transplantation (185)
- Urology (165)